COVID-19: We are vigilantly monitoring the situation in Europe and have precautions in place for our customers and our employees.
We maintain delivery services and continue to serve with as minimal disruption as possible. Updated May 25, 2020

Virbac
Rilexine 300 mg for dogs over 20 kg 1 tablet

Treatment of bacterial, cutaneous and urinary infections in dogs

Prescription required* (Exceptions apply)

Rilexine is for use in dogs.

Rilexine:

  • One tablet contains:

    • Active substance:
Name Cefalexin
Rilexine 75 mg 75.00 mg
Rilexine 300 mg 300.00 mg
Rilexine 600 mg 600.00 mg
  • List of excipients:
    • Crospovidone
    • Mannitol
    • Starch pregelantinised
    • Croscarmellose sodium
    • Collodial anhydrous silica
    • Collodial hydrated silica
    • Povidone K30
    • Microcrystalline cellulose type A
    • Poultry liver powder
    • Magnesium stearate
    • Microcrystalline cellulose type B

Rilexine Treatment:

  • Qualitative and quantitative composition:

    • Cefalexin (as monohydrate) 200.00 mg
    • Buthylhydroxyanisole (E 320) 1.80 mg
    • Excipient QSP 1 x 10 ml intramammary syringe
  • List of excipients:

    • Butylated hydroxyanisole (E 320)
    • Hydrogenated castor oil
    • Peanut oil

Rilexine:

  • For the treatment of bacterial skin infections in dogs (including deep and superficial pyodermas) caused by organisms susceptible to Cefalexin.
  • For the treatment of cutaneous and subcutaneous infections (wounds and abscesses) in cats caused by organisms susceptible to Cefalexin.
  • For the treatment of urinary-tract infections in cats and dogs (including nephritis and cystitis) caused by organisms susceptible to Cefalexin.
  • Do not use in animals which are known to be hypersensitive to penicillins and cephalosporins.
  • Do not use in rabbits, guinea pigs, hamsters and gerbils.

Rilexine Treatment:

  • Cattle (in lactating cows):

    • Cefalexin-sensitive mammary germ disorders in lactating cows.
    • Treatment of clinical mastitis with Staphylococcus aureus, Streptococcus dysgalactiae, Streptococcus uberis and Escherichia coli.

Rilexine:

  • 15 mg of Cefalexin per kg of bodyweight twice daily (equivalent to 30 mg per kg of bodyweight per day) for a duration of:

    • 5 days in case of cutaneous and subcutaneous infections (wounds and abscesses) in cats.
    • 14 days in case of urinary-tract infection in dogs.
    • at least 15 days in case of superficial infectious dermatitis in dogs.
    • at least 28 days in case of deep infectious dermatitis in dogs.
  • To achieve this dosage, administer:
    • Rilexine 75 mg:
    • Cats and dogs: One tablet per 5 kg of bodyweight or ½ tablet per 2.5 kg of bodyweight.
    • Rilexine 300 mg:
    • Dogs: Twice daily, one tablet per 20 kg of bodyweight or ½ tablet per 10 kg of bodyweight.
    • Rilexine 600 mg:
    • Dogs: Twice daily, one tablet per 40 kg of bodyweight or ½ tablet per 20 kg of bodyweight
  • To ensure a correct dosage, body weight should be determined as accurately as possible to avoid underdosing.
  • Due to its palatable formulation, the product is well accepted by dogs but may be crushed or added to food if necessary.
  • In severe or acute conditions, the dose may be safely doubled.

Rilexine Treatment:

  • 200 mg of cefalexin per quarter, the contents of one syringe in each infected quarter, intramammary every 12 hours for two days after complete milking and disinfection of the teat end.

Rilexine is for use in dogs.

Rilexine:

  • One tablet contains:

    • Active substance:
Name Cefalexin
Rilexine 75 mg 75.00 mg
Rilexine 300 mg 300.00 mg
Rilexine 600 mg 600.00 mg
  • List of excipients:
    • Crospovidone
    • Mannitol
    • Starch pregelantinised
    • Croscarmellose sodium
    • Collodial anhydrous silica
    • Collodial hydrated silica
    • Povidone K30
    • Microcrystalline cellulose type A
    • Poultry liver powder
    • Magnesium stearate
    • Microcrystalline cellulose type B

Rilexine Treatment:

  • Qualitative and quantitative composition:

    • Cefalexin (as monohydrate) 200.00 mg
    • Buthylhydroxyanisole (E 320) 1.80 mg
    • Excipient QSP 1 x 10 ml intramammary syringe
  • List of excipients:

    • Butylated hydroxyanisole (E 320)
    • Hydrogenated castor oil
    • Peanut oil

Rilexine:

  • For the treatment of bacterial skin infections in dogs (including deep and superficial pyodermas) caused by organisms susceptible to Cefalexin.
  • For the treatment of cutaneous and subcutaneous infections (wounds and abscesses) in cats caused by organisms susceptible to Cefalexin.
  • For the treatment of urinary-tract infections in cats and dogs (including nephritis and cystitis) caused by organisms susceptible to Cefalexin.
  • Do not use in animals which are known to be hypersensitive to penicillins and cephalosporins.
  • Do not use in rabbits, guinea pigs, hamsters and gerbils.

Rilexine Treatment:

  • Cattle (in lactating cows):

    • Cefalexin-sensitive mammary germ disorders in lactating cows.
    • Treatment of clinical mastitis with Staphylococcus aureus, Streptococcus dysgalactiae, Streptococcus uberis and Escherichia coli.

Rilexine:

  • 15 mg of Cefalexin per kg of bodyweight twice daily (equivalent to 30 mg per kg of bodyweight per day) for a duration of:

    • 5 days in case of cutaneous and subcutaneous infections (wounds and abscesses) in cats.
    • 14 days in case of urinary-tract infection in dogs.
    • at least 15 days in case of superficial infectious dermatitis in dogs.
    • at least 28 days in case of deep infectious dermatitis in dogs.
  • To achieve this dosage, administer:
    • Rilexine 75 mg:
    • Cats and dogs: One tablet per 5 kg of bodyweight or ½ tablet per 2.5 kg of bodyweight.
    • Rilexine 300 mg:
    • Dogs: Twice daily, one tablet per 20 kg of bodyweight or ½ tablet per 10 kg of bodyweight.
    • Rilexine 600 mg:
    • Dogs: Twice daily, one tablet per 40 kg of bodyweight or ½ tablet per 20 kg of bodyweight
  • To ensure a correct dosage, body weight should be determined as accurately as possible to avoid underdosing.
  • Due to its palatable formulation, the product is well accepted by dogs but may be crushed or added to food if necessary.
  • In severe or acute conditions, the dose may be safely doubled.

Rilexine Treatment:

  • 200 mg of cefalexin per quarter, the contents of one syringe in each infected quarter, intramammary every 12 hours for two days after complete milking and disinfection of the teat end.
From
1
. . . .
1.18 €
From
10
. . . .
1.14 €
From
20
. . . .
1.10 €
From
30
. . . .
1.06 €
From
40
. . . .
1.02 €
From
100
. . . .
0.99 €
1.18
Order within 2h 29m 40s (before 12AM)
And receive your order
on Tuesday 9 June
AIR FREIGHT

Customers who buy this product, usually buy: